Leo Intelligence Group announces new industry heavy-weight conference: "The Future of Clinical Trials".

Online, May 4, 2010 (Newswire.com) - Denver, CO - May 3, 2010: Leo Intelligence Group, a research conference and webinar organization, has released the first wave of speakers for this year's flagship conference, "The Future of Clinical Trials".

• [Chair] Ms. Christina DiArcangelo, Associate Director, Clinical Contracts and Outsourcing, FibroGen
• [Chair] Mr. Bill Gwinn, Vice President, Clinical Informatics Solutions, i3 Pharma Informatics
• [Keynote] Mr. Ken Getz, Chairman, CISCRP & Senior Research Fellow, Tufts CSDD & Owner, CenterWatch
• [Keynote] Mr. Michael Marcarelli, Director, Office of Bioresearch and Monitoring, FDA
• Ms. Brenda Reese, Executive Director, West Coast Operations, DSP Clinical Research
• Ms. Karrie Hilsinger, Associate Director, Clinical Operations, Eisai
• Mr. Gary Urban, Director, Global Quality Management Systems, Paragon Biomedical
• Mr. David Gao, Director Clinical Development/Trial, Chief R&D, Visen Medical & Consultant, Clinical Trials, Pfizer
• More to be added soon...

About the conference:

The Future of Clinical Trials (www.futureoftrials.com) will focus on the transformation of current clinical trials. Discussions will emphasize regulatory changes, novel partnerships that have proven successful and why, Improved management strategies for trial success and the future of trial development.
What makes this conference unique?

The Future of Clinical Trials is designed as a hybrid-conference in that the unique price point ($795.00), placement near industry-shifting biotechnology companies (San Francisco, CA) and overall scope (25 scheduled presenters, 2 pre-conference workshops) allows delegates and presenters unparalleled learning outcomes at a staggering value.